Variants in CSMD2 and CSMD3 , genes involved in synaptogenesis, are associated with epilepsies

作者：Xiang Li, Lin Wang, Xiaoyu Liang, Hongwei Zhang, Jian‐Guo Shi, Jing Guo, Dongfang Zou, Jing Chen, Su‐Li He, Yanping Xie, Qian Peng, Jianping Zhu, Na He, Wei‐Wen Deng, Sheng Luo, Pengyu Wang, Dongming Zhang, Jinjian Zhu, Bing‐Mei Li, Guifu Geng, Zaifen Gao, Jie Wang, Wei‐Ping Liao, For the China Epilepsy Gene 1.0 Project · 发表于：Epilepsia · 年份：2025 · DOI：10.1111/epi.18539 · 被引用次数：7 · 研究领域：Epilepsy research and treatment、Neuroscience and Neuropharmacology Research、Glioma Diagnosis and Treatment

OBJECTIVE: The CSMD genes, including CSMD1, CSMD2, and CSMD3, encoding synaptic transmembrane proteins, play important roles in neuronal maturation, growth of dendrites, and processes of synapses. Our recent study showed that CSMD1 was associated with developmental epileptic encephalopathy (DEE) and generalized epilepsy. The significance of CSMD2 and CSMD3 in human disease is unknown. METHODS: Trio-based whole-exome sequencing was performed in patients with focal epilepsy without acquired etiologies. The gene-disease association was validated by excess and damaging effect of variants, genotype-phenotype correlation, and studies on spatial-temporal and single-cell expression. RESULTS: CSMD2 variants were identified in six and CSMD3 variants were identified in four cases with focal epilepsy. Additional CSMD3 variants were identified in three cases with febrile seizures plus and one case with infantile spasms. The variants included 1 de novo, 1 homozygous, and 12 pairs of compound heterozygous variants. All variants were missense except one and presented no or extremely low minor allele frequencies, which were significantly lower than that of benign variants and higher in excess by multiple statistical analyses. The gene-disease association was further supported by correlation between damage scoring of variants and phenotype severity. The three CSMD genes are expressed predominantly at early development stages, correlated with the neurodevelopment abnormalities/DEE. CSMD1 expres...